Correction: Cost-effectiveness of statins in older patients with myocardial infarction

被引：4
|
作者：
Ganz, DA [1 ]
Kuntz, KM
Benner, JS
Avorn, J
机构：
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2002年 / 136卷 / 08期
关键词：
D O I：
10.7326/0003-4819-136-8-200204160-00023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 635
页数：1
相关论文
共 50 条
  • [31] The price of a QALY—cost-effectiveness of statins in CKD
    Vivekanand Jha
    Gopesh K. Modi
    Nature Reviews Nephrology, 2013, 9 : 377 - 379
  • [32] Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction Analysis by Subgroups
    Lozano, Inigo
    Rondan, Juan
    Vegas, Jose M.
    Segovia, Eduardo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (01) : 107 - 108
  • [33] Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction
    Vianna Araujo, Denizar
    Rangel Tura, Bemardo
    Luiz Brasileiro, Antonio
    Luz Neto, Heitor
    Braz Pavao, Ana Luiza
    Teich, Vanessa
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2008, 90 (02) : 100 - 107
  • [34] COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH STREPTOKINASE IN ELDERLY PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION
    KRUMHOLZ, HM
    PASTERNAK, RC
    WEINSTEIN, MC
    FRIESINGER, GC
    RIDKER, PM
    TOSTESON, ANA
    GOLDMAN, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (01): : 7 - 13
  • [35] Cost-effectiveness of troponins in patients with chest pain who are at low risk for myocardial infarction.
    Natarajan, S
    Kinosian, B
    MEDICAL DECISION MAKING, 1998, 18 (04) : 461 - 461
  • [36] OPTIMAL DIAGNOSIS IN ACUTE MYOCARDIAL-INFARCTION - A COST-EFFECTIVENESS STUDY
    GRANDE, P
    CHRISTIANSEN, C
    PEDERSEN, A
    CHRISTENSEN, MS
    CIRCULATION, 1980, 61 (04) : 723 - 728
  • [37] Cost-effectiveness of a Digital Health Intervention for Acute Myocardial Infarction Recovery
    Bhardwaj, Vinayak
    Spaulding, Erin M.
    Marvel, Francoise A.
    LaFave, Sarah
    Yu, Jeffrey
    Mota, Daniel
    Lorigiano, Ting-Jia
    Huynh, Pauline P.
    Shan, Rongzi
    Yesantharao, Pooja S.
    Lee, Matthias A.
    Yang, William E.
    Demo, Ryan
    Ding, Jie
    Wang, Jane
    Xun, Helen
    Shah, Lochan
    Weng, Daniel
    Wongvibulsin, Shannon
    Carter, Jocelyn
    Sheidy, Julie
    McLin, Renee
    Flowers, Jennifer
    Majmudar, Maulik
    Elgin, Eric
    Vilarino, Valerie
    Lumelsky, David
    Leung, Curtis
    Allen, Jerilyn K.
    Martin, Seth S.
    Padula, William V.
    MEDICAL CARE, 2021, 59 (11) : 1023 - 1030
  • [38] THE COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY FOLLOWING ACUTE MYOCARDIAL-INFARCTION
    FENN, P
    GRAY, AM
    MCGUIRE, A
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1991, 45 (03): : 181 - 184
  • [39] Cost-effectiveness of primary PTCA and thrombolysis in the treatment of acute myocardial infarction
    Sagmeister, M
    Amann, FW
    Follath, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (33) : 1146 - 1151
  • [40] Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective
    Liang, Zhe
    Chen, Qi
    Yang, Fei
    Yan, Xianliang
    Zhang, Xuehui
    Chen, Xue
    Fang, Fang
    Zhao, Quanming
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 775 - 785
12345